Serologic and dna-based testing for congenital and perinatal infections

Pediatric Infectious Disease Journal

Volumn 16, Issue 12, 1997, Pages 1166-1175

  Litwin, Christine M ^a,b   Hill, Harry R ^a,b  

^a Division of Clinical Epidemiology   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Congenital infection; DNA based diagnostic testing; Perinatal infection; Serology

Indexed keywords

DNA;

CONGENITAL INFECTION; CONGENITAL RUBELLA SYNDROME; CONGENITAL SYPHILIS; CONGENITAL TOXOPLASMOSIS; CYTOMEGALOVIRUS INFECTION; DNA DETERMINATION; HERPES SIMPLEX VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LABORATORY DIAGNOSIS; NEWBORN; PARVOVIRUS; PERINATAL INFECTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SEROLOGY;

CYTOMEGALOVIRUS INFECTIONS; DNA; HERPES SIMPLEX; HUMANS; INFANT, NEWBORN; INFECTION; PARVOVIRIDAE INFECTIONS; RUBELLA; SEROLOGIC TESTS; SYPHILIS, CONGENITAL; TOXOPLASMOSIS, CONGENITAL;

EID: 0031452277     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-199712000-00013     Document Type: Review

References (108)

1. Ingall D. Perinatal infectious diseases: update 1990. Pediatr Infect Dis J 1990;9:761-2.
2. Dickinson J, Gonik B. Teratogenic viral infections. Clin Obstet Gynecol 1990;33:242-52.
3. Leland D, French ML, Kleiman MB, Schreiner RL. The use of TORCH titers. Pediatrics 1983;72:41-3.
4. Sever JL, Ellenberg JH, Ley AC, et al. Toxoplasmosis: maternal and pediatric findings in 23 000 pregnancies. Pediatrics 1988;82:181-92.
5. Desmonts G, Courvreur J. Congenital toxoplasmosis: a prospective study of 378 pregnancies. N Engl J Med 1974;290: 1110-6.
6. McCabe RE, Brooks RG, Dorfman RF, Remington JS. Clinical spectrum in 107 cases of toxoplasmic lymphadenopathy. Rev Infect Dis 1987;9:754-74.
7. Remington JS, Desmonts G. Toxoplasmosis. In: Remington JS, Klein JO, eds. Infectious diseases of the fetus and newborn infant. Philadelphia: Saunders, 1990:89-195.
8. Alford CA, Stagno S, Reynolds DW. Congenital toxoplasmosis: clinical, laboratory, and therapeutic considerations, with special reference to subclinical disease. Bull NY Acad Med 1974;50:160-81.
9. Fine JD, Arndt KA. The TORCH syndrome: a clinical review. J Am Acad Dermatol 1985;12:697-706.
10. Wilson CB, Remington JS, Stagno S, Reynolds DW. Development of adverse sequelae in children born with subclinical congenital Toxoplasma infection. Pediatrics 1980;66:767-74.
11. Daffos F, Forestier F, Capella-Pavlovsky M, et al. Prenatal management of 746 pregnancies at risk of congenital toxoplasmosis. N Engl J Med 1988;318:271-5.
12. Naot Y, Desmonts G, Remington JS. IgM enzyme-linked immunosorbent assay for the diagnosis of congenital Toxoplasma infection. J Pediatr 1981;98:32-6.
13. Remington JS, Eimstad WM, Araujo FG. Detection of immunoglobulin M antibodies with antigen-tagged latex particles in an immunosorbent assay. J Clin Microbiol 1983;17: 939-41.
14. Stepick-Biek P, Thulliez P, Araujo FG, Remington JS. IgA antibodies for diagnosis of acute congenital and acquired toxoplasmosis. J Infect Dis 1990;162:270-3.
15. Sabin AB, Feldman HA. Dyes as microchemical indicators of a new immunity phenomenon affecting a protozoon parasite (Toxoplasma). Science 1948;108:660-3.
16. Naot Y, Barnett EV, Remington JS. Method for avoiding false positive results occurring in immunoglobulin M enzyme-linked immunosorbent assays due to presence of both rheumatoid factor and antinuclear antibodies. J Clin Microbiol 1981;14:73-8.
17. Kean BH, Kimball AC. The complement-fixation test in the diagnosis of congenital toxoplasmosis. Am J Dis Child 1977; 131:21-8.
18. Desmonts G, Remington JS. Direct agglutination test for diagnosis of Toxoplasma infection: method for increasing sensitivity and specificity. J Clin Microbiol 1980;11:562-8.
19. Welch PC, Masur H, Jones TC, Remington JS. Serologic diagnosis of acute lymphadenopathic toxoplasmosis. J Infect Dis 1980;142:256-64.
20. Hohlfeld P, Daffos F, Costa JM, Thulliez P, Forestier F, Vidaud M. Prenatal diagnosis of congenital toxoplasmosis with a polymerase-chain-reaction test on amniotic fluid. N Engl J Med 1994;331:695-9.
21. Anonymous. Increase in rubella and congenital rubella syndrome: United States, 1988-1990. MMWR 1991;40: 93-9.
22. Chang TW. Rubella reinfection and intrauterine involvement. J Pediatr 1974;84:617-8.
23. Rubella prevention: recommendations of the Immunization Practices Advisory Committee. MMWR 1990;39:1-18.
24. Hanshaw HB, Dudgeon JA, Marshall WC. Viral diseases of the fetus and newborn. Philadelphia: Saunders, 1985:1-308.
25. Peckham CS: Clinical and laboratory study of children exposed in utero to maternal rubella. Arch Dis Child 1972; 47:571-7.
26. Menser MA, Forrest JM. Rubella: high incidence of defects in children considered normal at birth. Med J Aust 1974;1: 123-6.
27. Desmond MM, Fisher ES, Vorderman AL, et al. The longitudinal course of congenital rubella encephalitis in nonretarded children. J Pediatr 1978;93:584-91.
28. Meyer HM, Parman PD, Hopps HE. The clinical application of laboratory diagnostic procedures for rubella and measles (rubeola). Am J Clin Microbiol 1972;57:803-13.
29. Levin MJ, Oxman MN, Moore MG, Daniels SB, Scheer K. Diagnosis of congenital rubella in utero. N Engl J Med 1974;290:1187-8.
30. Chernesky MA, Mahogany JB. In: Balows A, Hausler WJ Jr, Herman KL, et al (eds): Manual of clinical microbiology. Washington, DC: American Society of Microbiology, 1991: 325-66.
31. Daffos F, Forestier F, Grangeot-Keros L, et al. Prenatal diagnosis of congenital rubella. Lancet. 1984;2:1-3.
32. Eilard T, Strannegard O. Rubella reinfection in pregnancy followed by transmission to the fetus. J Infect Dis 1974;129: 594-6.
33. Alpert G, Plotkin SA. A practical guide to the diagnosis of congenital infections in the newborn infant. Pediatr Clin North Am 1986;33:465-79.
34. Terry GM, Ho-Terry L, Warren RC, et al. First trimester prenatal diagnosis of congenital rubella: a laboratory investigation. Br Med J 1986;292:930-3.
35. Bosma TJ, Corbett KM, Eckstein MB, et al. Use of PCR for prenatal and postnatal diagnosis of congenital rubella. J Clin Microbiol 1995;33:2881-7.
36. Weller TH. The cytomegaloviruses: ubiquitous agents with protean clinical manifestations: part 2. N Engl J Med 1971;285:203-14.
37. Stagno S, Pass RF, Dworsky ME, Alford CA. Congenital and perinatal cytomegalovirus infections. Semin Perinatol 1983; 7:31-42.
38. Alford CA, Stagno S, Pass RF, Britt WJ. Congenital and perinatal cytomegalovirus infections. Rev Infect Dis 1990; 12:8745-53.
39. Stagno S, Pass RF, Dworsky ME, et al. Maternal cytomegalovirus infection and perinatal transmission. Clin Obstet Gynecol 1982;25:563-76.
40. Stagno S, Cloud G, Pass RF, et al. Factors associated with primary cytomegalovirus infection during pregnancy. J Med Virol 1984;12:347-53.
41. Fowler KB, Stagno S, Pass RF, et al. The outcome of congenital cytomegalovirus infection in relation to maternal antibody status. N Engl J Med 1992;326:663-7.
42. Pass RF, Stagno S, Myers GJ, Alford CA. Outcome of symptomatic congenital cytomegalovirus infection: results of a long-term longitudinal follow-up. Pediatrics 1980;66: 758-62.
43. Stagno S, Reynolds DW, Amos CS, et al. Auditory and visual defects resulting from symptomatic and subclinical cytomegalovirus and Toxoplasma infections. Pediatrics 1977;59: 669-78.
44. Stagno S, Reynolds DW, Tsiantos A, et al. Comparative serial virologic and serologic studies of symptomatic and subclinical congenitally and natally acquired cytomegalovirus infections. J Infect Dis 1975;132:568-77.
45. Sawyer MH, Edwards DK, Spector SA. Cytomegalovirus infection and bronchopulmonary dysplasia in premature infants. Am J Dis Child 1987;141:303-5.
46. Dylewski J, Chou S, Merigan TC. Absence of detectable IgM antibody during cytomegalovirus disease in patients with AIDS. N Engl J Med 1983;309:493.
47. Weiner CP, Naides SJ. Fetal survival after human parvovirus B19 infection: spectrum of intrauterine response in a twin gestation. Am. J. Perinatol 1992;9:66-8.
48. Lynch L, Daffos F, Emanuel D, et al. Prenatal diagnosis of fetal cytomegalovirus infection. Am J Obstet Gynecol 1991; 165:714-8.
49. Grose C, Weiner CP. Prenatal diagnosis of congenital cytomegalovirus infection: two decades later. Am J Obstet Gynecol 1990;163:447-50.
50. Stagno S. Diagnosis of viral infections of the newborn infant. Clin Perinatol 1981;8:579-89.
51. Atkins JT, Demmler GJ, Williamson WD, McDonald JM, Istas AS, Buffone GJ. Polymerase chain reaction to detect cytomegalovirus DNA in the cerebrospinal fluid of neonates with congenital infection. J Infect Dis 1994;169:1334-7.
52. Warren WP, Balcarek K, Smith R, Pass RF. Comparison of rapid methods of detection of cytomegalovirus in saliva with virus isolation in tissue culture. J Clin Microbiol 1992;30: 786-9.
53. Komorous JM, Wheeler CE, Briggaman RA, Caro I. Intrauterine herpes simplex infections. Arch Dermatol 1977;113: 918-22.
54. Hutto C, Arvin A, Jacobs R, et al. Intrauterine herpes simplex virus infections. J Pediatr 1987;110:97-101.
55. Schroth G, Gawehn J, Thron A, Vallbracht A, Voigt K. Early diagnosis of herpes simplex encephalitis by MRI. Neurology 1987;37:179-83.
56. Brown ZA, Vontver LA, Benedetti J, et al. Effects on infants of a first episode of genital herpes during pregnancy. N Engl J Med 1987;317:1246-51.
57. Prober CG, Sullender WM, Yasukawa LL, et al. Low risk of herpes simplex virus infections in neonates exposed to the virus at the time of vaginal delivery to mothers with recurrent herpes simplex virus infections. N Engl J Med 1987; 316:240-4.
58. Jenista JA. Perinatal herpesvirus infections. Semin Perinatol 1983;7:9-15.
59. Whitley RJ, Nahmias AJ, Visintine AM, Fleming CL, Alford CA. The natural history of herpes simplex virus infection of mother and newborn. Pediatrics 1980;66:489-94.
60. Whitley R, Arvin A, Prober C, et al. Predictors of morbidity and mortality in neonates with herpes simplex virus infections. N Engl J Med 1991;324:450-4.
61. Sullender WM, Miller JL, Yasukawa LL, et al. Humoral and cell-mediated immunity in neonates with herpes simplex virus infections. J Infect Dis 1987;155:28-37.
62. Kimura H, Futamura M, Kito H, et al. Detection of viral DNA in neonatal herpes simplex virus infections: frequent and prolonged presence in serum and cerebrospinal fluid. J Infect Dis 1991;164:289-93.
63. Rowley AH, Whitley RJ, Lakeman FD, Wolinsky SM. Rapid detection of herpes-simplex-virus DNA in cerebrospinal fluid of patients with herpes simplex encephalitis. Lancet 1990;335:440-1.
64. Kimberlin DW, Lakeman FD, Arvin AM, et al. Application of the polymerase chain reaction to the diagnosis and management of neonatal herpes simplex virus disease. J Infect Dis 1996;174:1162-7.
65. Anonymous. HIV testing among women aged 18-44 years: United States, 1991 and 1993. MMWR 1996;45:733-7.
66. Barnhart HX, Caldwell MB, Thomas P, et al. Natural history of human immunodeficiency virus disease in perinatally infected children: an analysis from the Pediatric Spectrum of Disease Project. Pediatrics 1996;97:710-16.
67. Ammann AJ. Advances in pediatric infectious diseases. 3 vols. Chicago: Year Book Medical Publishers, 1988.
68. Mok JQ, De Rossi A, Ades AE, et al. Infants born to mothers seropositive for human immunodeficiency virus: preliminary findings from a multicentre European study. Lancet 1987;1:1164-8.
69. Kovacs A, Xu J, Rasheed S, et al. Comparison of a rapid nonisotopic polymerase chain reaction assay with four commonly used methods for the early diagnosis of human immunodeficiency virus type 1 infection in neonates and children. Pediatr Infect Dis J 1995;14:948-54.
70. Rawstron SA, Bromberg K, Hammerschlag MR. STD in children: syphilis and gonorrhea. Genitourin Med 1993;69: 66-75.
71. Rolfs RT, Nakashima AK. Epidemiology of primary and secondary syphilis in the United States, 1981 through 1989. JAMA 1990;264:1432-7.
72. Anonymous. Primary and secondary syphilis: United States, 1981-1990. MMWR 1991;40:314-23.
73. Grossman J. Congenital syphilis. Teratology 1977;16:217-9.
74. Ikeda MK, Jenson HB. Evaluation and treatment of congenital syphilis. J Pediatr 1990;117:843-52.
75. Buchanan CS, Haserick JR. FTA-ABS test in pregnancy: a probable false-positive reaction. Arch Dermatol 1970;102: 322-5.
76. Stoll BJ, Lee FK, Larsen SA, et al. Clinical and serologic evaluation of neonates for congenital syphilis: a continuing diagnostic dilemma. J Infect Dis 1993;167:1093-9.
77. Larsen SA, Steiner BM, Rudolph AH. Laboratory diagnosis and interpretation of tests for syphilis. Clin Microbiol Rev 1995;8:1-21.
78. Kraus SJ, Haserick JR, Logan LC, Bullard JC. Atypical fluorescence in the fluorescent treponemal antibody-absorption (FTA-ABS) test related to deoxyribonucleic acid (DNA) antibodies. J Immunol 1971;106:1665-9.
79. Larsen SA, Hambie EA, Pettit DE, Perryman MW, Kraus SJ. Specificity, sensitivity, and reproducibility among the fluorescent treponemal antibody absorption test, the microhemagglutination assay for Treponema pallidum antibodies, and the hemagglutination treponemal test for syphilis. J Clin Microbiol 1981;14:441-5.
80. Sanchez PJ, Wendel GD, Grimprel E, et al. Evaluation of molecular methodologies and rabbit infectivity testing for the diagnosis of congenital syphilis and neonatal central nervous system invasion by Treponema pallidum. J Infect Dis 1993;167:148-57.
81. Wicher K, Noordhoek GT, Abbruscato F, Wicher V. Detection of Treponema pallidum in early syphilis by DNA amplification. J Clin Microbiol 1992;30:497-500.
82. Noordhoek GT, Wolters EC, de Jonge MEJ, van Embden JDA. Detection by polymerase chain reaction of Treponema pallidum DNA in cerebrospinal fluid from neurosyphilis patients before and after antibiotic treatment. J Clin Microbiol 1991;29:1976-84.
83. Grimprel E, Sanchez PJ, Wendel GD, et al. Use of polymerase chain reaction and rabbit infectivity testing to detect Treponema pallidum in amniotic fluid, fetal and neonatal sera, and cerebrospinal fluid. J Clin Microbiol 1991;29: 1711-8.
84. Burstain JM, Grimprel E, Lukehart SA, Norgard MV, Radolf JD. Sensitive detection of Treponema pallidum by using the polymerase chain reaction. J Clin Microbiol 1991; 29:62-9.
85. Anderson MJ, Lewis E, Kidd IM, Hall SM, Cohen BJ. An outbreak of erythema infectiosum associated with human parvovirus infection. J Hyg 1984;93:85-93.
86. Anderson MJ, Davis LR, Hodgson J, et al. Occurrence of infection with a parvovirus-like agent in children with sickle cell anaemia during a two-year period. J Clin Pathol 1982; 35:74-49.
87. Chorba T, Coccia P, Holman RC, et al. The role of parvovirus B19 in aplastic crisis and erythema infectiosum (fifth disease). J Infect Dis 1986;154:383-93.
88. Lefrere JJ, Courouce AM, Bertrand Y, Girot R, Soulier JP. Human parvovirus and aplastic crisis in chronic hemolytic anemias: a study of 24 observations. Am J Hematol 1986; 23:271-5.
89. Mortimer PP. Hypothesis: the aplastic crisis of hereditary spherocytosis is due to a single transmissible agent. J Clin Pathol 1983;36:445-8.
90. Anderson LJ. Role of parvovirus B19 in human disease. Pediatr Infect Dis J 1987;6:711-8.
91. Brown T, Anand A, Ritchie LD, Clewley JP, Reid TMS. Intrauterine parvovirus infection associated with hydrops fetalis. Lancet 1984;2:1033-4.
92. Knott PD, Welply GAC, Anderson MJ. Serologically proved intrauterine infection with parvovirus. Br Med J Clin Res Ed 1984;289:1660.
93. Anand A, Gray ES, Brown T, Clewley JP, Cohen BJ. Human parvovirus infection in pregnancy and hydrops fetalis. N Engl J Med 1987;316:183-6.
94. Bond PR, Caul EO, Usher J, et al. Intrauterine infection with human parvovirus. Lancet 1986;1:448.
95. Gray ES, Anand A, Brown T. Parvovirus infections in pregnancy. Lancet 1986;1:208.
96. Lefrere JJ, Dumez Y, Courouce AM, Deschene G. Intrauterine infection with human parvovirus. Lancet 1986;1:448-9.
97. Kinney JS, Anderson LJ, Farrar J, et al. Risk of adverse outcomes of pregnancy after human parvovirus B19 infections. J Infect Dis 1988;157:663-7.
98. Mortimer PP, Cohen BJ, Buckley MM, et al. Human parvovirus and the fetus. Lancet 1985;2:1012.
99. Woernle CH, Anderson LJ, Tattersall P, Davison JM. Human parvovirus infection during pregnancy. J Infect Dis 1987;156:17-20.
100. Anderson LJ, Tsou C, Parker RA, et al. Detection of antibodies and antigens of human parvovirus B19 by enzyme-linked immunosorbent assay. J Clin Microbiol 1986;24: 522-6.
101. Cohen BJ, Mortimer PP, Pereira MS. Diagnostic assays with monoclonal antibodies for the human serum parvovirus-like virus (SPLV). J Hyg 1983;91:113-30.
102. Azzi A, Trotta M, Zakrzewska K, et al. Human parvovirus B19 infection within a family and risk for pregnant women. Epidemiol Infect 1996;117:401-3.
103. Koch WC, Adler SP, Harger J. Intrauterine parvovirus B19 infection may cause an asymptomatic or recurrent postnatal infection. Pediatr J Infect Dis 1993;12:747-50.
104. Torok TJ, Wang Q, Gary GW, Yang C, Finch TM, Anderson LJ. Prenatal diagnosis of intrauterine infection with parvovirus B19 by the polymerase chain reaction technique. Clin Infect Dis 1992;14:149-55.
105. Schwarz TF, Jager G, Holzgreve W, Roggendorf M. Diagnosis of human parvovirus B19 infections by polymerase chain reaction. Scand J Infect Dis 1992;24:691-6.
106. Yamakawa Y, Oka H, Hori S, Arai T, Izumi R. Detection of human parvovirus B19 DNA by nested polymerase chain reaction. Obstet Gynecol 1995;86:126-9.
107. Brandenburg H, Los FJ, Cohen-Overbeek TE. A case of early intrauterine parvovirus B19 infection. Prenat Diagn 1996;16:75-7.
108. Naides SJ, Weiner CP. Antenatal diagnosis and palliative treatment of non-immune hydrops fetalis secondary to fetal parvovirus B19 infection. Prenat Diagn 1989;9:105-14.